Prospective Liver Study

Emory University400 enrolled

Overview

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Liver Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment. Exclusion Criteria: * Severe liver disfunction * Active uncontrolled infection * Significant underlying medical of physical illness

Locations (1)

Emory University

Atlanta, Georgia, United States

Outcomes

Primary Outcomes

Assess efficacy of percutaneous and transarterial treatments for liver cancer.

QOL questionnaire will be collected during follow up visit.

Time frame: 1 month

Secondary Outcomes

long term follow up

Patients will be administered QOL during 3 months, 6 months and 1 year follow up.

Time frame: 3 months, 6 months 1year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.